Blood biomarker study for brain tumor patients
Part of Brain & nervous system, Cancer clinical trials.
This study collects blood (and looks at samples) from adults who have a confirmed brain tumor, either one that started in the brain or one that spread to the brain. The goal is to understand biomarkers—signals in the body—that may help improve diagnosis or tracking over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be an adult (age requirements may still be checked by the study team).
- Have a confirmed primary brain tumor or a metastatic brain tumor (from elsewhere).
- Provide proof of diagnosis, using pathology (tissue results) or imaging (scan results) as the study requires.
- Be willing to have study sample collection done (for example, blood).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how cancer and its treatment affect thinking and memory. It may help doctors understand and predict these changes, which could improve care.
This trial studies brain scan findings to see if specific imaging markers can help understand or predict outcomes in people with brain metastases. It may help researchers improve how brain metastases are evaluated before radiation treatment.
This study looks at different immune cells in the blood and inside brain tumors. It includes adults who have a malignant brain tumor and need a neurosurgery procedure, such as surgery, stereotactic biopsy, or radiosurgery, to help doctors better understand the immune response.
This trial uses a small piece of your brain tumor after surgery to test which drugs might work best for you. It helps doctors find the most effective treatment for your specific tumor.
This study collects biological samples from adults with a confirmed brain tumor. Samples may help researchers better understand brain tumors and improve future treatments.
This study is looking at a blood marker (a type of chemical change in cells) to see if it can help predict how solid tumor cancers will behave. If you have a solid tumor cancer, this research might help doctors understand your condition better.
Hear when a new Brain Tumor, Primary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.